CompletedPhase 4NCT00307671

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

Studying Anti-neutrophil cytoplasmic antibody-associated vasculitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Loïc Guillevin, MD,PhD
Assistance Publique - Hôpitaux de Paris
Intervention
prednisone, methylprednisolone,cyclophosphamides(drug)
Enrollment
108 enrolled
Eligibility
65 years · All sexes
Timeline
20052011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00307671 on ClinicalTrials.gov

Other trials for Anti-neutrophil cytoplasmic antibody-associated vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Anti-neutrophil cytoplasmic antibody-associated vasculitis

← Back to all trials